Related Experiment Video
Updated: Aug 7, 2026
07:08
Fractionation for Resolution of Soluble and Insoluble Huntingtin Species
Published on: February 27, 2018
Juvenile-onset Huntington's disease: a challenging diagnosis
Toni Saad1, Andrew Norman2, Hilary A Archer3
1Neurology, Gloucestershire Royal Hospital, Gloucester, UK toni.saad@nhs.net.
Practical Neurology
|August 5, 2026
Summary
Juvenile-onset Huntington's disease presents uniquely, differing from adult forms. Early diagnosis requires recognizing subtle signs like oculomotor apraxia and detailed patient history, confirmed by genetic testing.
Area of Science:
- Neurology
- Genetics
- Pediatric Neurology
Background:
- Juvenile-onset Huntington's disease (JHD) presents atypically compared to adult-onset Huntington's disease.
- Diagnostic challenges arise due to numerous confounding symptoms in pediatric patients.
- Familiarity with adult Huntington's disease presentation can mislead clinicians regarding JHD.
Purpose of the Study:
- To describe the diagnostic journey of a patient with juvenile-onset Huntington's disease.
- To highlight the importance of specific clinical signs and detailed history in diagnosing JHD.
- To reflect on the challenges encountered in diagnosing JHD.
Main Methods:
- Case report detailing a complex diagnostic process.
- Identification of key clinical features, including oculomotor apraxia.
- Reconstitution of a detailed patient timeline.
- Confirmation of diagnosis via genetic testing.
Main Results:
- The diagnosis of Huntington's disease was delayed due to atypical presentation and distractors.
- Elicitation of specific signs like oculomotor apraxia was crucial.
- Genetic testing confirmed the Huntington's disease diagnosis.
Conclusions:
- Juvenile-onset Huntington's disease requires a high index of suspicion and careful clinical evaluation.
- Oculomotor apraxia and a thorough patient history are vital diagnostic clues for JHD.
- Genetic confirmation remains essential for definitive diagnosis of Huntington's disease.
Keywords:
HUNTINGTON-SMore Related Videos
05:52Handwriting Analysis Indicates Spontaneous Dyskinesias in Neuroleptic Naïve Adolescents at High Risk for Psychosis
Published on: November 21, 2013
10:52Efficient and Scalable Production of Full-length Human Huntingtin Variants in Mammalian Cells using a Transient Expression System
Published on: December 10, 2021
Related Concept Videos
01:21Huntington Disease l: Introduction
Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:26Cushing Syndrome I: Introduction
Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the syndrome.Exogenous...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...